Coronavirus Update: Will Dexamethasone Breakthrough Make Remdesivir Irrelevant?

Plus AZ's Vaccine May Only Protect For One Year

 
• By Scrip Team
  
Old Road Campus
The University of Oxford, which is leading the multi-arm RECOVERY trial
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip